Does the target of an Hb value of 13.5 g/dL versus 11.3 g/dL in EPO-managed stages 3 and 4 chronic renal disease decrease cardiovascular events and mortality?
¿La diana de Hb de 13,5 g/dl frente a 11,3 g/dl, en el tratamiento con EPO en la enfermedad renal crónica estadios 3 y 4, disminuye los sucesos cardiovasculares y la mortalidad?
R. Saracho
Read
3300
Timeswas read the article
387
Total PDF
2913
Total HTML
Article information
ISSN: 20132514Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 27 | 0 | 27 |
| 2025 5 | 62 | 0 | 62 |
| 2025 4 | 48 | 0 | 48 |
| 2025 3 | 71 | 0 | 71 |
| 2025 2 | 60 | 0 | 60 |
| 2025 1 | 33 | 0 | 33 |
| 2024 12 | 40 | 0 | 40 |
| 2024 11 | 34 | 0 | 34 |
| 2024 10 | 38 | 0 | 38 |
| 2024 9 | 46 | 0 | 46 |
| 2024 8 | 54 | 0 | 54 |
| 2024 7 | 30 | 0 | 30 |
| 2024 6 | 33 | 0 | 33 |
| 2024 5 | 48 | 0 | 48 |
| 2024 4 | 31 | 0 | 31 |
| 2024 3 | 23 | 3 | 26 |
| 2024 2 | 27 | 11 | 38 |
| 2024 1 | 25 | 7 | 32 |
| 2023 12 | 14 | 7 | 21 |
| 2023 11 | 28 | 9 | 37 |
| 2023 10 | 27 | 14 | 41 |
| 2023 9 | 23 | 9 | 32 |
| 2023 8 | 23 | 5 | 28 |
| 2023 7 | 25 | 6 | 31 |
| 2023 6 | 29 | 4 | 33 |
| 2023 5 | 25 | 8 | 33 |
| 2023 4 | 20 | 3 | 23 |
| 2023 3 | 14 | 0 | 14 |
| 2023 2 | 19 | 4 | 23 |
| 2023 1 | 17 | 1 | 18 |
| 2022 12 | 27 | 2 | 29 |
| 2022 11 | 24 | 2 | 26 |
| 2022 10 | 20 | 1 | 21 |
| 2022 9 | 21 | 3 | 24 |
| 2022 8 | 30 | 4 | 34 |
| 2022 7 | 13 | 1 | 14 |
| 2022 6 | 14 | 1 | 15 |
| 2022 5 | 27 | 2 | 29 |
| 2022 4 | 19 | 1 | 20 |
| 2022 3 | 23 | 4 | 27 |
| 2022 2 | 19 | 3 | 22 |
| 2022 1 | 15 | 0 | 15 |
| 2021 12 | 15 | 11 | 26 |
| 2021 11 | 24 | 0 | 24 |
| 2021 10 | 20 | 1 | 21 |
| 2021 9 | 14 | 2 | 16 |
| 2021 8 | 17 | 3 | 20 |
| 2021 7 | 25 | 3 | 28 |
| 2021 6 | 18 | 2 | 20 |
| 2021 5 | 15 | 1 | 16 |
| 2021 4 | 34 | 8 | 42 |
| 2021 3 | 22 | 1 | 23 |
| 2021 2 | 20 | 5 | 25 |
| 2021 1 | 20 | 5 | 25 |
| 2020 12 | 9 | 0 | 9 |
| 2020 11 | 18 | 5 | 23 |
| 2020 10 | 6 | 0 | 6 |
| 2020 9 | 8 | 2 | 10 |
| 2020 8 | 24 | 6 | 30 |
| 2020 7 | 21 | 1 | 22 |
| 2020 6 | 18 | 2 | 20 |
| 2020 5 | 20 | 6 | 26 |
| 2020 4 | 27 | 3 | 30 |
| 2020 3 | 22 | 6 | 28 |
| 2020 2 | 22 | 3 | 25 |
| 2020 1 | 27 | 6 | 33 |
| 2019 12 | 32 | 3 | 35 |
| 2019 11 | 20 | 4 | 24 |
| 2019 10 | 3 | 0 | 3 |
| 2019 9 | 15 | 1 | 16 |
| 2019 8 | 15 | 2 | 17 |
| 2019 7 | 10 | 3 | 13 |
| 2019 6 | 19 | 6 | 25 |
| 2019 5 | 6 | 1 | 7 |
| 2019 4 | 27 | 9 | 36 |
| 2019 3 | 16 | 0 | 16 |
| 2019 2 | 11 | 5 | 16 |
| 2019 1 | 4 | 0 | 4 |
| 2018 12 | 23 | 11 | 34 |
| 2018 11 | 17 | 6 | 23 |
| 2018 10 | 24 | 8 | 32 |
| 2018 9 | 15 | 14 | 29 |
| 2018 8 | 11 | 6 | 17 |
| 2018 7 | 17 | 8 | 25 |
| 2018 6 | 10 | 9 | 19 |
| 2018 5 | 16 | 11 | 27 |
| 2018 4 | 9 | 5 | 14 |
| 2018 3 | 13 | 6 | 19 |
| 2018 2 | 8 | 3 | 11 |
| 2018 1 | 16 | 8 | 24 |
| 2017 12 | 15 | 7 | 22 |
| 2017 11 | 8 | 5 | 13 |
| 2017 10 | 9 | 8 | 17 |
| 2017 9 | 5 | 4 | 9 |
| 2017 8 | 10 | 5 | 15 |
| 2017 7 | 6 | 3 | 9 |
| 2017 6 | 10 | 5 | 15 |
| 2017 5 | 5 | 2 | 7 |
| 2017 4 | 5 | 2 | 7 |
| 2017 3 | 7 | 1 | 8 |
| 2017 2 | 8 | 3 | 11 |
| 2017 1 | 4 | 1 | 5 |
| 2016 12 | 17 | 3 | 20 |
| 2016 11 | 19 | 3 | 22 |
| 2016 10 | 27 | 5 | 32 |
| 2016 9 | 39 | 4 | 43 |
| 2016 8 | 79 | 0 | 79 |
| 2016 7 | 71 | 0 | 71 |
| 2016 6 | 63 | 0 | 63 |
| 2016 5 | 68 | 0 | 68 |
| 2016 4 | 62 | 0 | 62 |
| 2016 3 | 25 | 0 | 25 |
| 2016 2 | 21 | 0 | 21 |
| 2016 1 | 20 | 0 | 20 |
| 2015 12 | 64 | 0 | 64 |
| 2015 11 | 23 | 0 | 23 |
| 2015 10 | 31 | 0 | 31 |
| 2015 9 | 12 | 0 | 12 |
| 2015 8 | 23 | 0 | 23 |
| 2015 7 | 35 | 0 | 35 |
| 2015 6 | 7 | 0 | 7 |
| 2015 5 | 46 | 0 | 46 |
Show all
